Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3859 ARTÍCULOS , VIENDO DEL 1261 AL 1275

Myoclonus-dystonia caused by GNB1 mutation responsive to deep brain stimulation

Jones HF, Morales-Briceño H, Barwick K, Lewis J, Sanchis-Juan A, Raymond FL, Stewart K, Waugh MC, Mahant N, Kurian MA, Dale RC, Mohammad SS.

Mov Disord. 2019 Jul;34(7):1079-1080. doi: 10.1002/mds.27708. Epub 2019 Apr 29.

Use of botulinum toxin for movement disorders

Camargo CHF, Teive HAG.

Drugs Context. 2019 Jun 18;8:212586. doi: 10.7573/dic.212586. eCollection 2019.

Psychiatric and Behavioral Complications of GPi DBS in an Adolescent with Myoclonus Dystonia

Kriegel G, Stuckey MI.

Case Rep Psychiatry. 2019 Jun 4;2019:1947962. doi: 10.1155/2019/1947962. eCollection 2019.

Psychogenic (Functional) Movement Disorders

Thenganatt MA, Jankovic J.

Continuum (Minneap Minn). 2019 Aug;25(4):1121-1140. doi: 10.1212/CON.0000000000000755.

A Novel SGCE Nonsense Variant Associated With Marked Intrafamilial Variability in a Turkish Family With Myoclonus-Dystonia

Gultekin M, Prakash N, Ganos C, Mirza M, Bayramov R, Bhatia KP, Mencacci NE.

Mov Disord Clin Pract. 2019 Jul 17;6(6):479-482. doi: 10.1002/mdc3.12805. eCollection 2019 Jul.

Gait Impairment in Myoclonus-Dystonia (DYT-SGCE)

Haeri G, Shahidi G, Fasano A, Rohani M.

Tremor Other Hyperkinet Mov (N Y). 2019 Aug 2;9. doi: 10.7916/tohm.v0.656. eCollection 2019.

[Zonisamide treatment in myoclonus-dystonia]

Salamon A, Zádori D, Horváth E, Vécsei L, Klivényi P.

Orv Hetil. 2019 Aug;160(34):1353-1357. doi: 10.1556/650.2019.31472.

Twenty years on: Myoclonus-dystonia and ε-sarcoglycan - neurodevelopment, channel, and signaling dysfunction

Menozzi E, Balint B, Latorre A, Valente EM, Rothwell JC, Bhatia KP.

Mov Disord. 2019 Nov;34(11):1588-1601. doi: 10.1002/mds.27822. Epub 2019 Aug 26.

Vertical and Radial Attentional Neglect in Corticobasal Syndrome

Julayanont P, Burks DW, Heilman KM.

Cogn Behav Neurol. 2019 Sep;32(3):208-213. doi: 10.1097/WNN.0000000000000204.

A South African family with myoclonus-dystonia syndrome with a novel mutation in the SGCE gene responding to deep brain stimulation

van Coller R, Bardien S, Neethling A, Carr J, Schutte C.

Parkinsonism Relat Disord. 2019 Nov;68:63-64. doi: 10.1016/j.parkreldis.2019.10.001. Epub 2019 Oct 7.

Quality of life outcomes after deep brain stimulation in dystonia: A systematic review

Tsuboi T, Wong JK, Okun MS, Ramirez-Zamora A.

Parkinsonism Relat Disord. 2020 Jan;70:82-93. doi: 10.1016/j.parkreldis.2019.11.016. Epub 2019 Nov 18.

Shared demographics and comorbidities in different functional motor disorders

Gelauff JM, Rosmalen JGM, Gardien J, Stone J, Tijssen MAJ.

Parkinsonism Relat Disord. 2020 Jan;70:1-6. doi: 10.1016/j.parkreldis.2019.11.018. Epub 2019 Nov 23.

Subcortical Myoclonus and Associated Dystonia in 22q11.2 Deletion Syndrome

Van Iseghem V, McGovern E, Apartis E, Keren B, Vidailhet M, Roze E, Degos B.

Tremor Other Hyperkinet Mov (N Y). 2020 Jan 24;10. doi: 10.7916/tohm.v0.729. eCollection 2019.

Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies

Hamed SA.

Expert Rev Clin Pharmacol. 2019 Jan;12(1):61-90. doi: 10.1080/17512433.2019.1555468. Epub 2019 Jan 11.

Erratic movement disorders disclosing Graves' disease and paralleling thyroid function but not autoantibody levels

Delhasse S, Debove I, Arnold-Kunz G, Ghika JA, Chabwine JN.

J Int Med Res. 2019 Mar;47(3):1378-1386. doi: 10.1177/0300060518816873. Epub 2019 Feb 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias